Field note · April 2026 · ~9 min read
Three uncomfortable questions from 2025 Canadian earnings season.
FY 2025 prints are in. Headline numbers across Canadian energy, materials, and infrastructure were generally strong. Records on production, dividends raised, buybacks executed, EBITDA at or above guidance. None of that is wrong. It is just not the read. The read lives one layer down, and it points at three questions most of the sell-side decks did not ask out loud.
Question 01Did per-share dividend growth actually beat share-count growth?
The most-quoted line in 2025 earnings calls was the dividend raise. CNQ's twenty-sixth consecutive raise. Enbridge's thirty-first. Suncor and TC Energy in the same neighbourhood. The headline number is the percentage by which the per-share dividend went up.
The number that matters is what happened to the share count on the way there. A 6% dividend raise funded by 6% equity issuance is not a 6% raise. It is a rounding error wearing a press release. The reverse is also true: a 3% headline raise stacked on top of a 3% buyback is closer to a 6% effective return to the holders who stayed.
| Operator | Headline raise | Share count Δ | Per-share Δ |
|---|---|---|---|
| CNQ Canadian Natural | +6.4% | +0.8% | +5.6% |
| SU Suncor | +5.0% | −3.2% | +8.4% |
| NTR Nutrien | +2.0% | −1.8% | +3.9% |
| TRP TC Energy | +3.3% | +1.0% | +2.3% |
| ENB Enbridge | +3.0% | +5.5% | −2.4% |
Figure 01
Headline raise vs. real per-share growth, FY 2025.
Same five operators. The gap between the two bars is the part the press release does not cover. Enbridge's headline raise was the clearest casualty of equity-financed acquisition; Suncor's was the cleanest beneficiary of disciplined buybacks.
The honest read
Streaks are real. Streaks are also accounting outputs, not arithmetic. Suncor ran the cleanest 2025 from a shareholder's perspective: a modest headline raise stacked on a real buyback. Enbridge raised a streak of dividend increases by issuing meaningful equity to fund the Dominion utilities; the per-share dividend implicitly went backwards in 2025. That is not the same as the deal being a mistake, but it is the asterisk no investor relations slide will print.
A 6% raise funded by 6% issuance is not a raise. It is a rounding error wearing a press release.
Question 02What did TMX actually do to Mainline apportionment?
The Trans Mountain Expansion came online in May 2024 and ramped through 2024 and into 2025. It added a structurally new ~590 thousand barrels per day of egress for Western Canadian heavy crude to the Pacific. The bear case on Enbridge's Mainline going into 2025 was simple: with a real second pipe, shippers will defect, throughput will fall, apportionment will go to zero, and the Mainline's pricing power evaporates.
The data did not cooperate with that case.
| Period | Apportionment % | WCSB prod. Δ YoY | TMX utilization |
|---|---|---|---|
| 2023 (full yr) | ~5% | +0.10 Mbbl/d | — |
| 2024 H1 (pre-TMX) | ~7% | +0.12 Mbbl/d | — |
| 2024 H2 | ~3% | +0.13 Mbbl/d | ~55% |
| 2025 H1 | ~5% | +0.16 Mbbl/d | ~70% |
| 2025 H2 | ~6% | +0.15 Mbbl/d | ~80% |
Figure 02
Apportionment did not collapse. Two pipes filled.
After a brief dip in late 2024 as TMX ramped, the Mainline returned to mid-single-digit apportionment. The implied conclusion: WCSB production growth absorbed both pipes simultaneously rather than draining one for the other.
The honest read
The bear case priced the Mainline as if WCSB production were static. It is not. Heavy oil out of Alberta and Saskatchewan added roughly 300 thousand barrels per day across 2024–2025, and the basin still has expansions on deck through the end of the decade. The Mainline did not get cannibalised; it got company. Until that production growth stalls, the apportionment risk is theoretical. We are watching the back half of the decade carefully — but not yet. Halvren's full Enbridge writeup is here.
Question 03Where did 2025 production growth actually come from?
Several names printed double-digit production growth in 2025. CNQ at +15%. Enbridge at record EBITDA up roughly 6%. The headline reads as operational excellence. The composition reads differently.
Acquired growth and organic growth count the same in the income statement and they count differently in everything else. Acquired growth is paid for in equity, debt, or cash; organic growth is paid for in capital that the existing balance sheet generates. Acquired growth resets the leverage clock; organic growth winds it down. Acquired growth needs an integration thesis; organic growth needs a drilling plan. They do not deserve the same multiple, and the market often gives them the same one anyway in the year of the print.
| Operator | Headline Δ | Acquired | Organic |
|---|---|---|---|
| CNQ prod. | +15.0% | +13.0% | +2.0% |
| ENB EBITDA | +6.0% | +4.0% | +2.0% |
| IMO prod. | +1.0% | 0% | +1.0% |
| SU prod. | +2.0% | 0% | +2.0% |
| TOU prod. | +6.0% | 0% | +6.0% |
Figure 03
Two operators printed big numbers. One of them drilled them.
CNQ and ENB earned the headlines. Tourmaline earned the underlying business. Same year, same earnings season, very different stories under the hood.
The honest read
CNQ's AOSP top-up looks like a strong deal at the cost-curve test. Enbridge's Dominion utilities look like a defensible long-duration rate-base trade. Both are likely fine. But the print they generated in 2025 was a one-shot composition effect. The people who keep watching the same number in 2026 and 2027 are the ones who get to know whether it was acquisition arithmetic or operating talent. Tourmaline is the one operator on this list whose 2025 number is clearly the latter.
Acquired growth and organic growth count the same in the income statement and count differently in everything else.
What we are watching into Q1 2026 prints.
- Per-share dividend trajectory for the names with elevated 2024–2025 share issuance. Enbridge in particular: do the Dominion utilities generate enough rate-base earnings in 2026 to put per-share dividend growth back in positive territory?
- Mainline apportionment data through the seasonal cycle, and TMX utilization at the back end of 2026. Sustained zero apportionment would be the cleanest signal that the bear case is finally arriving.
- 2026 organic production guidance for CNQ and Enbridge — the year where acquisition tailwinds wash out and the underlying business has to carry the print.
- The buyback / issuance ratio across the universe. A 2026 in which dividends rise on top of net buybacks (Suncor's 2025 template) is the cleanest fundamental setup we have seen in a decade.
Methodology & sourcing
Figures. Headline dividend raises and FY 2025 production / EBITDA prints are taken from each operator's Q4 / full-year 2025 release issued February–March 2026. Share-count deltas use weighted average diluted share counts, year-over-year. Per-share dividend deltas reconcile the headline raise against the share-count change for the same period (approximation, not GAAP).
Mainline apportionment. Apportionment percentages are CER-disclosed monthly figures for the Enbridge Mainline system, averaged to the period stated. WCSB production deltas use AER and Saskatchewan Ministry of Energy and Resources monthly data. TMX utilization is sourced from Trans Mountain Corporation operational disclosures and pipeline filings.
Production / EBITDA decomposition. Acquired vs. organic split estimated from the company's pro-forma disclosure where available, otherwise apportioned by the contribution period of the named acquisition (CNQ: AOSP / Duvernay closed Q4 2024; ENB: Dominion gas utilities closed across 2024). Organic figures are the residual.
What this is not.
- Not a price call on any name listed.
- Not a recommendation to buy, sell, or hold any security.
- Not portfolio commentary; Halvren's holdings are proprietary and undisclosed at the position level.
Caveats. Figures are rounded for legibility. Definitions vary by issuer and we have used a consistent Halvren methodology rather than each issuer's preferred metric. The point of the field note is to surface a question, not to be the audited report. The audited report lives in the cited filings.
This field note is for informational and educational purposes only and is not a recommendation, solicitation, or price call. The author may hold positions in any of the names discussed and may transact at any time without notice. See the Terms of Use for the full disclaimer. The companion writeups for CNQ, Cameco, First Majestic, Nutrien, and Enbridge live in the research archive; the underlying methodology lives on the process page.